Literature DB >> 9169143

Characterization of the human and rat phospholemman (PLM) cDNAs and localization of the human PLM gene to chromosome 19q13.1.

L S Chen1, C F Lo, R Numann, M Cuddy.   

Abstract

Previous reports have demonstrated that the phospholemman (PLM), a 72-residue plasma-membrane protein enriched in skeletal muscle and heart, is a major substrate phosphorylated in response to insulin and adrenergic stimulation. Here we describe the isolation and characterization of human and rat PLM cDNA from the heart. Both PLM proteins share significant nucleotide and amino acid sequence and structural similarities with the previously published canine PLM and, to a lesser degree, with Na+/K(+)-ATPase gamma subunit, Mat-8 protein, and CHIF protein. Despite the functional diversity, all these proteins are quite small and possess a single transmembrane domain. Human PLM appears to be a unique gene localized on chromosome 19q13.1. The PLM mRNA is widely distributed in human tissues, with the highest expression in skeletal muscle and heart, suggesting a functional role in muscle contraction. Like canine PLM, both human and rat PLM induce a hyperpolarization-activated chloride current when expressed in Xenopus oocytes. The high degree of sequence and functional conservation among the mammalian PLM proteins indicates that this gene is conserved throughout evolution.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169143     DOI: 10.1006/geno.1997.4665

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

Review 1.  Molecular and functional studies of the gamma subunit of the sodium pump.

Authors:  A G Therien; H X Pu; S J Karlish; R Blostein
Journal:  J Bioenerg Biomembr       Date:  2001-10       Impact factor: 2.945

2.  Intracellular trafficking of FXYD1 (phospholemman) and FXYD7 proteins in Xenopus oocytes and mammalian cells.

Authors:  Shiri Moshitzky; Carol Asher; Haim Garty
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

3.  Inhibition of insulin-stimulated phosphorylation of the intracellular domain of phospholemman decreases insulin-dependent GLUT4 translocation in streptolysin-O-permeabilized adipocytes.

Authors:  O Walaas; R S Horn; S I Walaas
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

Review 4.  Phospholemman: a novel cardiac stress protein.

Authors:  Joseph Y Cheung; Xue-Qian Zhang; Jianliang Song; Erhe Gao; Joseph E Rabinowitz; Tung O Chan; Jufang Wang
Journal:  Clin Transl Sci       Date:  2010-08       Impact factor: 4.689

5.  Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties.

Authors:  Gilles Crambert; Maria Fuzesi; Haim Garty; Steven Karlish; Kathi Geering
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

6.  Isoform specificity of the Na/K-ATPase association and regulation by phospholemman.

Authors:  Julie Bossuyt; Sanda Despa; Fei Han; Zhanjia Hou; Seth L Robia; Jerry B Lingrel; Donald M Bers
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

7.  Effects of phospholemman expression on swelling-activated ion currents and volume regulation in embryonic kidney cells.

Authors:  Cristina E Davis; Manoj K Patel; James R Miller; J Edward John; Larry R Jones; Amy L Tucker; J Paul Mounsey; J Randall Moorman
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

8.  Phospholemman, a single-span membrane protein, is an accessory protein of Na,K-ATPase in cerebellum and choroid plexus.

Authors:  Marina S Feschenko; Claudia Donnet; Randall K Wetzel; Natalya K Asinovski; Larry R Jones; Kathleen J Sweadner
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

Review 9.  Function of FXYD proteins, regulators of Na, K-ATPase.

Authors:  Käthi Geering
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 3.853

Review 10.  Roles of Key Ion Channels and Transport Proteins in Age-Related Hearing Loss.

Authors:  Parveen Bazard; Robert D Frisina; Alejandro A Acosta; Sneha Dasgupta; Mark A Bauer; Xiaoxia Zhu; Bo Ding
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.